Myelination across the autism spectrum: therapeutic targeting of the oligodendrocyte lineage and myelination defects
Neuropsychopharmacology
.
2026 Jan;51(1):343-344.
doi: 10.1038/s41386-025-02209-w.
Authors
Hyejung Won
1
,
Brady J Maher
2
3
4
Affiliations
1
Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
2
Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. brady.maher@libd.org.
3
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. brady.maher@libd.org.
4
The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA. brady.maher@libd.org.
PMID:
40877558
PMCID:
PMC12618666
(available on
2027-01-01
)
DOI:
10.1038/s41386-025-02209-w
No abstract available
Publication types
News
Grants and funding
R01MH110487/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
R01MH134828/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)